Seasonal pharmacological properties and alkaloid content in Cyrtanthus contractus N.E. Br.

• There were significant variations (667.4-1020.6 μg/g) in alkaloid levels between different months of the year
• Cytotoxic effects, AChE and COX enzyme inhibitory activity were excellent for extracts collected in May and September
• Environment has a significant role on the quality of plant extracts

Representatives of the genus Cyrtanthus including Cyrtanthus contractus of the Amaryllidaceae family are widely used in African traditional medicine for the treatment of a range of ailments, including mental illness and age-related dementia. The alkaloid constituents distributed within the genus, which are chiefly responsible for the biological activity of the derived extracts, are thought to be influenced by changes in the growing environment. Natural growing populations of C. contractus were tagged and collected every 15th day of each month over a 12 month period. The ethanol bulb extracts from each of the collected samples were evaluated for total alkaloid content, cytotoxic effects, acetylcholinesterase and cyclooxygenase inhibition as well as antimicrobial activities. Some notable bioactivities were recorded for extracts collected during certain months of the year, particularly the cytotoxic effects against human cancer cell lines and enzyme inhibition (AChE and COX). The cytotoxic effects and AChE and COX enzyme inhibitory activities of extracts collected in May and September are of considerable interest. Similarly total alkaloids varied markedly from one month to the other. The bioactivity exhibited by C. contractus bulb extracts during certain months of the year, particularly in May and September, justifies the collection and use of these bulbs for treatment of the relevant ailments in traditional medicine during these periods.